[Microbiological diagnostic and antibiotic management of community aquired and nosocomial pneumonias in intensive care units in Germany].
Meyer
E
E
Institut für Umweltmedizin und Krankenhaushygiene, Universitätsklinikum Freiburg. smeyer@iuk3.ukl.uni-freiburg.de
Ebner
W
W
Heininger
A
A
Schwab
F
F
Rüden
H
H
Daschner
F D
FD
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D002511:Cephalosporins / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D003428:Cross Infection / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005858:Germany / Q000453:epidemiology; D017408:Guidelines as Topic; D006801:Humans; D007362:Intensive Care Units; D010406:Penicillins / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D011159:Population Surveillance; D012121:Respiration, Artificial / Q000009:adverse effects; D011795:Surveys and Questionnaires; D065093:beta-Lactamase Inhibitors
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004791:Enzyme Inhibitors; D010406:Penicillins; D065093:beta-Lactamase Inhibitors; D010878:Piperacillin